We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dual Treatment for Spinal Cord Compression

By HospiMedica staff writers
Posted on 01 Sep 2005
A team of UK researchers has evaluated traditional surgical and radiation therapy options for patients with spinal cord compression due to metastatic cancer and concluded that direct compressive surgery plus postoperative radiotherapy are more effective than either therapy alone or other surgical options.

Metastatic epidural spinal cord compression (MESCC), a common complication of cancer, occurs in 5-14% of cancer patients. More...
Standard treatment consists of corticosteroids and radiotherapy. However, following this therapy, only 50% of patients are able to walk.
Surgery in the form of laminectomy was used before radiotherapy was available but was abandoned after a small trial in 1980 showed no benefit.

A UK research team of Dr. Roy Patchell and colleagues at the University of Kentucky (Lexington, USA) conducted a randomized, multi-institutional, nonblinded trial assessing the efficacy of surgery and radiotherapy combinations in more than 100 patients with spinal cord compression caused by metastatic cancer. The results were so overwhelmingly in favor of the compressive surgery and radiotherapy combination that the study was halted.

These results showed that 84% of patients who received both surgery and radiotherapy were able to walk after treatment, versus only 57% of patients who received only radiation. Moreover, they were able to walk significantly longer and were less dependent on corticosteroids and opiod analgesics. The findings were reported in the August 20, 2005, issue of The Lancet.




Related Links:
U. of Kentucky

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.